BRAF and neoplasm: This included collating studies of Sanger sequencing hot spot regions in BRAF, NRAS, and KIT, identifying rare but recurrent functionally relevant non‐hot spot variants, which otherwise would not have been uncovered, highlighting the importance of analyzing larger tumor collections.